SYNAIRGEN PLC

Major Shareholding Notification • Mar 8, 2022

National Storage Mechanism | Additional information

RNS Number : 0818E

Synairgen plc

08 March 2022

Synairgen plc

("Synairgen" or the "Company")

Holding(s) in Company

Synairgen was informed on 8 March 2022 that Polar Capital LLP no longer has a disclosable interest in the Company.

For further information, please contact:

Synairgen plc 

Richard Marsden, Chief Executive Officer

John Ward, Chief Financial Officer

Brooke Clarke, Head of Communications  

Tel: +44 (0) 23 8051 2800

finnCap (NOMAD and Joint Broker)

Geoff Nash, Kate Bannatyne, Charlie Beeson (Corporate Finance)

Alice Lane, Sunil de Silva (ECM)

Tel: +44 (0) 20 7220 0500

Numis Securities Limited (Joint Broker)

James Black, Freddie Barnfield, Duncan Monteith

Tel: +44 (0) 20 7260 1000

Consilium Strategic Communications (Financial Media and Investor

Relations)

Mary-Jane Elliott, Jessica Hodgson, Lucy Featherstone

synairgen@consilium-comms.com

Tel: +44 (0) 20 3709 5700

MK Strategies, LLC (US Media Relations)

Mary Conway

MConway@MKCStrategies.com

Tel: +1 516 606 6545

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

HOLFLFVRVLITIIF